Overview
Lewis Attas is a Hematologist and an Oncologist in Englewood, New Jersey. Dr. Attas is rated as an Advanced provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, EGFR Positive Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). Dr. Attas is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
350 Engle St, 5th Fl Rm 5518, Englewood, NJ 07631
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
New York University
Bruce Raphael is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Raphael is rated as a Distinguished provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Bone Marrow Aspiration.
Trustees Of Columbia University In The City Of New York
Andrew Eisenberger is a Hematologist and an Oncologist in New York, New York. Dr. Eisenberger is rated as an Advanced provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Myelodysplastic Syndrome (MDS), Thrombocytopenia, Pulmonary Embolism, Thrombectomy, and Splenectomy.
Memorial Hematology Lymphoma Group
Aaron Goldberg is a Hematologist and an Oncologist in New York, New York. Dr. Goldberg is rated as a Distinguished provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Attas isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Breast CancerDr. Attas isDistinguished. Learn about Breast Cancer.
- EGFR Positive Lung CancerDr. Attas isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Attas isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Attas isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Attas isDistinguished. Learn about Lung Cancer.
- Advanced
- AnemiaDr. Attas isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Attas isAdvanced. Learn about Angiosarcoma.
- Bernard-Soulier SyndromeDr. Attas isAdvanced. Learn about Bernard-Soulier Syndrome.
- Chronic B-Cell Leukemia (CBCL)Dr. Attas isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Colorectal CancerDr. Attas isAdvanced. Learn about Colorectal Cancer.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Attas isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Promyelocytic LeukemiaDr. Attas isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Attas isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Attas isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Attas isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Attas isExperienced. Learn about Alveolar Soft Part Sarcoma.